Clinical Trials Browser

Phase 4 × Lymphoma, Extranodal NK-T-Cell × Clear all

NCT04999878 2021-08-11

RUE-DDGP

Phase 4 Unknown

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04490590 2020-07-29

A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT04038411 2019-07-30

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT01501136 2015-07-17

CTTNKTL-I/II

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT01501149 2015-07-17

CTTNKTL-Ⅲ/Ⅳ

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell